The vaccine, TAK-003, is the second dengue vaccine to be prequalified by WHO. WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission ...
A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it ...
, opens new tab dengue vaccine, giving international procurement agencies another option against the disease that affects millions of people each year. The approval, called a prequalification ...
The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...
The World Health Organisation has prequalified TAK-003 as a new vaccine for dengue (break-bone fever). This was according to a press statement released by the WHO on Wednesday on its website.
(MENAFN- IANS) New Delhi, May 15 (IANS) The World health Organisation (WHO) on Wednesday announced that it has prequalified Japanese drug maker Takeda's dengue vaccine. The live-attenuated TAK-003 ...
Argentine health authorities Thursday announced that the Japanese-developed TAK-003 vaccine against dengue was already available in the South American country at a cost of AR$ 37,500 (around US$ ...
(MENAFN- Caribbean News Global) GENEVA, Switaerland – A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue ...
World Health Organization (WHO) has officially prequalified a new vaccine designed to combat the mosquito-borne viral disease; dengue fever.The WHO announced a news release, that the new vaccine for ...
KUALA LUMPUR - The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is the second dengue vaccine to be prequalified by WHO.
TAK-003 is the second dengue vaccine to be prequalified by WHO Geneva: The World Health Organization (WHO) said on Wednesday that it had prequalified Takeda Pharmaceuticals' dengue vaccine.
Amidst the persistent global threat of dengue fever, a breakthrough has emerged with WHO granting pre-qualification to a new vaccine for the mosquito-borne disease. This significant development ...